Product Recall of Duloxetine: Cymbalta Bottles Affected by Toxic Chemical

Overview of the Product Recall

In a significant product recall, thousands of bottles containing duloxetine, marketed under the brand name Cymbalta, have been recalled. This action comes in light of concerns over the presence of a toxic chemical, N-nitroso-duloxetine, which can pose serious health risks.

Details of the Recall

The recall was initiated on October 10 by the Food and Drug Administration (FDA). N-nitroso-duloxetine is classified as a chemical that is toxic if ingested and is believed to have potential carcinogenic properties.

Health Implications and Guidance

The FDA has categorized this recall as Class II, suggesting that while the use of this drug could cause temporary health issues, it is not expected to result in long-term harm. Consumers are urged to check their medicine cabinets for affected products.

Next Steps for Consumers

• Check your stock for duloxetine under the Cymbalta brand.
• Return the affected bottles to the pharmacy or dispose of them properly.
• Consult with your healthcare provider if you have concerns or experience any adverse effects.